Meena Stoke

Company: Stoke Therapeutics

Job title: Vice President of Bioanalytical, DMPK & Biomarker Development

Seminars:

Challenges in Designing Pre-Clinical Toxicity Studies for Oligonucleotides & Their Clinical Relevance 11:30 am

Lessons learned from approved oligonucleotide therapeutics (ONTs) Lack of specific regulatory guidance for development of ONTs Considerations for development of ONTsRead more

day: Day One